These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6419237

  • 1. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P, Matintalo M, Dahl ML.
    Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T, Hoshida S, Yamagishi M, Ohmori M, Inoue M, Kamada T, Tada M.
    Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
    [Abstract] [Full Text] [Related]

  • 8. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
    Shikano M, Ito T, Ogawa K, Satake T.
    Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
    [Abstract] [Full Text] [Related]

  • 9. The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.
    Punnonen K, Uotila P, Mäntylä E.
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):367-74. PubMed ID: 6431566
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.
    Rolland PH, Bory M, Leca F, Sainsous J, Gueydon E, Juhan I, Serradimigni A, Cano JP.
    Prostaglandins Leukot Med; 1984 Dec; 16(3):333-46. PubMed ID: 6396656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T, Ikeda T, Ishimitsu T, Uehara Y.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [Abstract] [Full Text] [Related]

  • 14. Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy.
    Jouve R, Rolland PH, Delboy C, Mercier C.
    Am Heart J; 1984 Jan; 107(1):45-52. PubMed ID: 6581715
    [Abstract] [Full Text] [Related]

  • 15. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
    Laustiola K, Seppälä E, Nikkari T, Vapaatalo H.
    J Cardiovasc Pharmacol; 1984 Jan; 6(3):449-54. PubMed ID: 6202971
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H, Ochi H, Muramoto Y, Yasuda H, Tsuruta M, Maruyama Y.
    Thromb Res; 1986 Aug 15; 43(4):455-68. PubMed ID: 3094191
    [Abstract] [Full Text] [Related]

  • 20. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M, Felisi O, Boukhchache D, Sicard B, Dechavanne M.
    Thromb Res; 1984 Jul 15; 35(2):141-7. PubMed ID: 6089369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.